US 7365092
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted A61KA61K31/40A61K45/06
Quick answer
US patent 7365092 (Inhibitors of serine proteases, particularly HCV NS3-NS4A protease) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 50
- CPC classes
- A61K, A61K31/40, A61K45/06, A61P, A61P31/12